Juno Theraputics completed its IPO
On Dec. 23, 2014, Juno Therapeutics announced the closing of its initial public offering of 12.7 million shares…
On Dec. 23, 2014, Juno Therapeutics announced the closing of its initial public offering of 12.7 million shares…
On Mar. 25, 2014, the University of Minnesota Foundation announced that Caroline Amplatz had made early fulfillment of…
On Dec. 3, 2013, Juno Theraputics, a biotechnology company focused on bringing forward novel immunotherapies for cancer, was…
On Oct. 24, 2013, the University of Iowa (IA) announced a second $10 million gift commitment from Jerre…
On Jul. 25, 2012, in a meta-analysis, researchers from the China Medical University in Shenyang and Harvard School…
On Apr. 30, 2011, The University of Minnesota Masonic Children’s Hospital opened a new, innovative building for mothers…
On Nov. 18, 2010, AGA Medical was acquired by St. Jude Medical for $1.3 billion in cash. The…
On Jan. 25, 2010, St. Jude Children’s Research Hospital and Washington University School of Medicine launched a $65…
On Oct. 20, 2009, AGA Medical, based in Plymouth, designed and sold small devices that closed defects in…
On Feb 10, 2009, Caroline Amplatz pledged $50-million to the Minnesota Medical Foundation, in Minneapolis, to support the…
On Jul. 29, 2008, the Caroline Pryce Walker Childhood Cancer Act of 2007 amended the Public Health Service…
On Aug. 11, 2005, the Food and Drug Administration (FDA) approved an application of a pediatric/adolescent formulation of…
On Jun. 20, 2003, Genentech drug Xolair (omalizumab) was approved by the U. S. Food and Drug Administration…
On Jan. 4, 2002, President George W. Bush signed P.L. 107-109 – S. 1789, the Best Pharmaceuticals for…
On Jan. 4, 2002, The Best Pharmaceuticals for Children Act was signed into law, established a process for…
In 2002, the U.S. Congress passed the Best Pharmaceuticals for Children Act that improved safety and efficacy of…
In 1998, Doernbecher Children’s Hospital’s new state-of-the-art pediatric medical complex was opened. Built with private funding and bond…
In 1997, Kurt Amplatz invented the Amplatzer Septal Occluder. The device is inserted by percutaneous catheter placement, thus…
In 1997, Kurt Amplatz, MD and son-in-law Frank Gougeon founded AGA Medical. The company, based in Plymouth, designed…
On Oct. 25, 1996, the first gene therapy trial for patients with Hunter syndrome was begun at the…
In 1996, Kurt Amplatz performed one of the first percutaneous catheterization of the heart. Amplatz, M.D., who was…
On May 3, 1995, the U.S. Food & Drug Administration (FDA) announced it had approved Genentech’s drug CellCept…
On Feb. 22, 1995, the first inactivated hepatitis A vaccine, distributed by SmithKline Beecham Pharmaceuticals (Philadelphia, Pennsylvania), was…
In 1995, the Immunization Practices Advisory Committee (ACIP), American Academy of Pediatrics, and the American Association of Family…
In 1995, Kurt Amplatz, M.D. created Goose-Neck Snares which are used to retrieve broken catheters and other items…
On Oct. 26, 1994, a 12-year-old boy from Everett underwent the first heart transplant at Children’s Hospital and…
On Sept. 8, 1993, Joycelyn Elders, an American pediatrician and public health administrator and the first African American…
In 1988, the Center for AIDS Research at Albert Einstein Cancer Center was funded by the National Institutes…
On Nov. 30, 1987, scientists at the University of California at San Diego and Wills Eye Hospital announced…
In 1984, St. ᅠJude Children’s Hospital launched the After Completion of Therapy Clinic, the world’s largest long-term follow-up…